Previous 10 | Next 10 |
Inventor, Researcher, Medical Device Manufacturer Executive Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorder...
Gainers: Trxade (MEDS) +100%, Reneo Pharmaceuticals (RPHM) +13%, ProPhase Labs (PRPH) +18%, Verona Pharma (VRNA) +13%, Myomo (MYO) +8%.Losers: Aethlon Medical (AEMD) -28%, Ocugen (OCGN) -23%, Ra Medical Systems (RMED) -16%, SCWo...
Myomo's management has a history of diluting shareholders. The firm is still burning cash. Therefore, I will pass on this stock. Myomo claims it will become cash flow positive in Q4 by increasing direct billing, but it has already done that in the past few years without getting to bre...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today provided an update regarding its applicati...
RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The Summer Solstice - Best Ideas fro...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that CEO Paul R. Gudonis and CFO...
Myomo has a revolutionary product that allows people with paralyzed arms to use them once more. Triple-digit growth will be fuelled by a number of catalysts both in the US as well as internationally. Key KPIs hit record levels in Q1 as Myomo ramped up advertising after the electio...
Myomo, Inc. (MYO) Q1 2021 Earnings Conference Call May 05, 2021 16:30 P.M. ET Company Participants Kim Golodetz - Lippert/Heilshorn & Associates David A. Henry - CFO Paul R. Gudonis - Chairman, President, & CEO Conference Call Participants Scott Henry - ROTH Capital Partners Kayla Hos...
Myomo (MYO): Q1 GAAP EPS of -$0.57.Revenue of $2.34M (+131.7% Y/Y)Press Release For further details see: Myomo reports Q1 results
Revenue of $2.3 million up 132% over prior year Gross margin of 73% up 500 basis points over prior year Q1 cash used in operations decreased 14% to $2.1 million Conference call begins at 4:30 p.m. Eastern time today Myomo, Inc. (NYSE American: MYO) (...
News, Short Squeeze, Breakout and More Instantly...
2024-07-10 17:00:05 ET Scott Henry from Industrial Alliance Securities issued a price target of $5.75 for MYO on 2024-07-10 15:33:00. The adjusted price target was set to $5.75. At the time of the announcement, MYO was trading at $4.97. The overall price target consensus...
2024-07-10 16:15:02 ET Alliance Global Partners analyst issues BUY recommendation for MYO on July 10, 2024 03:33PM ET. The previous analyst recommendation was Buy. MYO was trading at $4.97 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
2024-07-09 10:30:11 ET Lake Street analyst issues BUY recommendation for MYO on July 9, 2024 08:45AM ET. The previous analyst recommendation was Buy. MYO was trading at $4.07 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst...